Pamidronate

Records for this ingredient, by country (identity only).

ATC M05BA03 · 6 markets · 69 records

Pamidronate 6 markets · 69 records Forms
Filters

GB 30 records · 12 shown of 13 Source NHSBSA dm+d · Data as of 2026-10-19

Other strengths: 1 · 1 dosage forms Otras concentraciones: 1 · 1 formas farmacéuticas 其余规格 1 个 · 涉及 1 种剂型 其餘規格 1 個 · 涉及 1 種劑型 · 15 mg/1 mL

CA 12 records · 5 shown of 5 Source Health Canada Drug Product Databas · Data as of 2026-10-23

US 5 records · 3 shown of 3 Source openFDA NDC Directory · Data as of 2026-10-23

  • 9 mg per mL / per unit basis not statedinjectionManufacturer: Hospira, Inc. ×3Manufacturer: Mylan Institutional LLC
  • 3 mg per mL / per unit basis not statedinjectionManufacturer: Hospira, Inc. ×3Manufacturer: Mylan Institutional LLC
  • 6 mg per mL / per unit basis not statedinjectionManufacturer: Hospira, Inc. ×3

AU 3 records · 2 shown of 2 Source PBS Schedule API v3 (Department of、TGA CMI repository (consumer medic · Data as of 2026-10-01、live · some records have no stated strength · includes records with unknown status (not proof of sale)

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

FR 3 records · 3 shown of 3 Source Base de données publique des médic · Data as of 2026-11-03

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.